ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
04/17/201517:29:38Statement of Changes in Beneficial Ownership (4)
04/14/201508:44:32The Growing Business Of Animal Healthcare
04/13/201517:22:11Amended Statement of Ownership (sc 13g/a)
04/13/201510:36:35Earnings And GDP Temporarily Take Investor Spotlight Off The...
04/09/201512:47:41Proxy Statement (definitive) (def 14a)
04/09/201511:34:49Value Stocks For DIY Investors
04/09/201508:00:00Valeant Pharmaceuticals To Announce 2015 First Quarter Results...
04/09/201508:00:00Valeant Pharmaceuticals To Announce 2015 First Quarter Results...
04/08/201513:36:22Horizon Pharma And Hyperion Therapeutics: Still Upside Or Not?
04/07/201516:55:39Current Report Filing (8-k)
04/05/201509:52:02Can This Pharma Go From Good to Great?
04/03/201516:00:00Seeking Alpha's Biotech Weekly: Billion Dollar Deals, Gilead...
04/02/201515:48:04Statement of Changes in Beneficial Ownership (4)
04/02/201515:39:18Statement of Changes in Beneficial Ownership (4)
04/02/201515:25:36Statement of Changes in Beneficial Ownership (4)
04/02/201515:12:55Statement of Changes in Beneficial Ownership (4)
04/01/201517:50:00CNO Financial Group Set to Join the S&P MidCap 400
04/01/201517:00:00Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental...
04/01/201517:00:00Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental...
04/01/201517:00:00Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental...

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad